Navigation Links
CTDC Announces the Disposal of Non-core Business
Date:12/20/2007

-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Act of 1934. These statements relate to future events or the Company's future financial performance. The Company has attempted to identify forward-looking statements by terminology including "anticipates", "believes", "expects", "can", "continue", "could", "estimates", "expects", "intends", "may", "plans", "potential", "predict", "should", or "will" or the negative of these terms or other comparable terminology. These statements are only predictions, uncertainties and other factors may cause the Company's actual results, level of activity, performance or achievements to be materially different from any future results, level of activity, performance or achievements expressed or implied by these forward-looking statements. The information in this Report on Form 6-K is not intended to project future performance of the Company. Although the Company believes that the expectations reflected in the forward- looking statements are reasonable, the Company does not guarantee future results, level of activity, performance or achievements. The Company's expectations are as of the date this Form 6-K is filed, and the Company does not intend to update any of the forward-looking statements after the date this Report on Form 6-K is filed to conform these statements to actual results, unless required by law.

Enquiries:

Stephan Yao

General Manager, PR/IR Department

Tel: +852-3112-8461

Email: ir@chinactdc.com


'/>"/>
SOURCE China Technology Development Group Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...wire-FirstCall/ -- eResearchTechnology, Inc.,(eRT...lized ECG and eClinical,technology, ePRO and othe...medical device and related industries, announced t...President and Chief Executive Officer, and Keith,...e scheduled to present at,the Piper Jaffray Healt...
(Date:12/2/2008)...wswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical,...nd supplier,of modernized traditional Chinese med...unced the implementation of a new sales and market...hospital clients into three classes in order,to o... The new strategy has classified distributors i...
(Date:12/2/2008)...RNewswire/ -- GeneGo, Inc., the leading systems bi...has become a certified GeneGo Center of Excellence...ccess to GeneGo,s MetaCore data analysis suite, tr...e is a world-class biomedical research facility ru...ut many departments, including research in cancer,...
(Date:12/2/2008)..., December 2 NicOx S.A.,... signed an agreement with,DSM for the commercial ...ce,(or API, active pharmaceutical ingredient). Na...and the first compound in the,Cyclooxygenase-Inhi...i-inflammatory agents, which recently achieved pos...
Breaking Biology Technology:eResearchTechnology, Inc. to Present at the Piper Jaffray Health Care Conference on December 2, 2008 2Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 2Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 3The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology 2NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 2NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 3NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 4
...y Systems Inc. said it has raised $1.4 million in... , ,The company, now about a year old, is developi...generating and using hydrogen fuel in car engines.... method involves generating it from water and suga...ve a chemical reaction. , ,The firm said Advantage...
Culver,s, a fast-food chain native to Wisconsin, is working with Madison Environmental Group on a kit to make cars run on old frying oil. Meanwhile, online extortionists are holding personal files fo
...t tolerating unexpected difference. The boxes tend...a spike in their power curve or an unanticipated c... us that way. The difference, of course, is our ab...e recognize it and choose to do something about it...ok like their pets. Do we begin to look like, act ...
...rket failed to reach double-digit growth in 2004 f... for this focused on concerns over drug safety, pr...products had their patents expire. , ,Let,s take a...the estimates of IMS Health, a pharmaceutical mark...e pharmaceutical market slowed down, one important...
Other Biology Technology:Machine like me 2Machine like me 3Though pharma growth slides, blockbusters reach new record 2Though pharma growth slides, blockbusters reach new record 3
(Date:12/1/2008)...D, Calif. Scientists around the world may benefit...online, that will help them to home in on the part..., Arend Sidow, PhD, associate professor of pathol...ool of Medicine, recently launched the novel bioin...de to determining the role different proteins play...
(Date:12/1/2008)...National Academy of Sciences will hold a colloquiu...es of the nature of niches of organisms. Leading r...predict future patterns of distribution and even e...ology, phylogenetics, and biodiversity informatics...of the Sackler Colloquium series, the event will t...
(Date:12/1/2008)...r, CO, USA The December Geosphere , The Geologic...Topics include detailed data integration from mult...dimentology, and paleontology, to study the southw...ion years ago; sedimentation in a piggyback basin;..., Nevada; and a study of the South Balkan extensio...
(Date:12/1/2008)...IDENCE, R.I. [Brown University] Gray mold is a ga...scientific name Botrytis cinerea , is a scourge t...species, including staples such as tomatoes, straw... endive, peas, peppers, and potatoes. Gray mold en...oxin that poisons the host plants, cells, eventual...
Breaking Biology News(10 mins):Powerful online tool for protein analysis provided pro bono by Stanford geneticist 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 3December Geosphere media highlights 2December Geosphere media highlights 3Brown chemist finds gray mold's killer gene 2CyberKnife System Achieves 38 Percent Growth in Extracranial Treatments During Fiscal Year 2008 8564 1CyberKnife System Achieves 38 Percent Growth in Extracranial Treatments During Fiscal Year 2008 8564 2CyberKnife System Achieves 38 Percent Growth in Extracranial Treatments During Fiscal Year 2008 8564 3CyberKnife System Achieves 38 Percent Growth in Extracranial Treatments During Fiscal Year 2008 8564 4Angiotech Announces Webcast and Call in Numbers for Annual and Special General Meeting of Shareholders 8561 1Johnson 26 Johnson Pharmaceutical Research 26 Development L L C Submits New Drug Application to FDA for Carisbamate 8559 1Johnson 26 Johnson Pharmaceutical Research 26 Development L L C Submits New Drug Application to FDA for Carisbamate 8559 2Johnson 26 Johnson Pharmaceutical Research 26 Development L L C Submits New Drug Application to FDA for Carisbamate 8559 3Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology 3332 1Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology 3332 2Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology 3332 3
..., a director at the Max Planck Institute of Bioche...the beginning of the 1990s that blocking blood ves... and shrinks its tissue. This fundamental principl...ingredient is Sunitinib. SUTENT® was recently appr... is expected to be brought onto the German market ...
...Comprehensive Cancer Center say that just one, sin...e cancer in mice. The discovery offers new insight...d lymphoma and at the same time underscores the po... RNA play in cell signaling pathways active in car...s is the first direct evidence that overexpression...
...ysed rocks from seabeds millions of years old. Car...ass 12 (99 percent) and atomic mass 13 (1 percent)...were characterised by a relatively strong increase...sed by a sudden large-scale release of carbon from...s. , The atmospheric carbon dioxide concentration...
...ept at blending in with their surroundings, cuttle...terns and can switch between them almost instantan...entists, to appear in the May 2006 issue of the jo...asters of disguise change their appearance based o...olorblind. , While previous research has reported ...
Other Biology News:Basic research leads to a novel cancer therapy 2Basic research leads to a novel cancer therapy 3Basic research leads to a novel cancer therapy 4Single microRNA causes cancer in transgenic mouse 2Single microRNA causes cancer in transgenic mouse 3Carbon cycle was already disrupted millions of years ago 2Cuttlefish masters of disguise despite colorblindness 2
ANTI ALPHA FSH:B
Beagle Serum • Beagle serum is collected from fasted Beagle canines of mixed sex over one year of age Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Pot
MOUSE ANTI HUMAN MBP (67-74) Immunogen: Human myelin basic protein
MOUSE ANTI BOVINE TROPONIN I
Biology Products: